| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |